Related content

Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line

By Qi Hui wei   Shen Zan   Fan Li hong  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite

Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring

By Gatineau M.  

Targeted Oncology, Vol. 1, Iss. 3, 2006-07 ,pp. : 114-122

Springer Publishing Company

Access to resources Recommend Favorite

Isolation and characterization of erlotinib-resistant human non-small cell lung cancer A549 cells

By Ikeda Ryuji   Vermeulen Lee C.   Lau Elim   Jiang Zhisheng   Kavanaugh Shannon M.   Yamada Katsushi   Kolesar Jill M.  

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 91-94

Spandidos Publications

Access to resources Recommend Favorite

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

By                  

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1599-1600

Spandidos Publications

Access to resources Recommend Favorite

Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells

By                        

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 237-243

Spandidos Publications

Access to resources Recommend Favorite